Novel Approach to Cancer Immunotherapy Shows Promise – Genetic Engineering & Biotechnology News
News-Medical.net |
Novel Approach to Cancer Immunotherapy Shows Promise
Genetic Engineering & Biotechnology News “A majority of cancers fail to respond to immunotherapy with antibodies targeting immune checkpoints, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed death-1 (PD-1)/PD-1 ligand (PD-L1). Cancers frequently express transforming growth … Efficacy of cancer immunotherapy increased by deactivating tumor defence mechanism |
